International guideline development for the determination of death
INTRODUCTION AND METHODS: This report summarizes the results of the first phase in the development of international guidelines for death determination, focusing on the biology of death and the dying process, developed by an invitational forum of international content experts and representatives of a number of professional societies.
RESULTS AND CONCLUSIONS: Precise terminology was developed in order to improve clarity in death discussion and debate. Critical events in the physiological sequences leading to cessation of neurological and/or circulatory function were constructed. It was agreed that death determination is primarily clinical and recommendations for preconditions, confounding factors, minimum clinical standards and additional testing were made. A single operational definition of human death was developed: 'the permanent loss of capacity for consciousness and all brainstem functions, as a consequence of permanent cessation of circulation or catastrophic brain injury'. In order to complete the project, in the next phase, a broader group of international stakeholders will develop clinical practice guidelines, based on comprehensive reviews and grading of the existing evidence.
| Errataetall: |
CommentIn: Intensive Care Med. 2015 Mar;41(3):571. - PMID 25708418 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Intensive care medicine - 40(2014), 6 vom: 28. Juni, Seite 788-97 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shemie, Sam D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 20.02.2015 Date Revised 17.03.2022 published: Print-Electronic CommentIn: Intensive Care Med. 2015 Mar;41(3):571. - PMID 25708418 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00134-014-3242-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM236714511 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM236714511 | ||
| 003 | DE-627 | ||
| 005 | 20231224110139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00134-014-3242-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0789.xml |
| 035 | |a (DE-627)NLM236714511 | ||
| 035 | |a (NLM)24664151 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shemie, Sam D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a International guideline development for the determination of death |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.02.2015 | ||
| 500 | |a Date Revised 17.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Intensive Care Med. 2015 Mar;41(3):571. - PMID 25708418 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION AND METHODS: This report summarizes the results of the first phase in the development of international guidelines for death determination, focusing on the biology of death and the dying process, developed by an invitational forum of international content experts and representatives of a number of professional societies | ||
| 520 | |a RESULTS AND CONCLUSIONS: Precise terminology was developed in order to improve clarity in death discussion and debate. Critical events in the physiological sequences leading to cessation of neurological and/or circulatory function were constructed. It was agreed that death determination is primarily clinical and recommendations for preconditions, confounding factors, minimum clinical standards and additional testing were made. A single operational definition of human death was developed: 'the permanent loss of capacity for consciousness and all brainstem functions, as a consequence of permanent cessation of circulation or catastrophic brain injury'. In order to complete the project, in the next phase, a broader group of international stakeholders will develop clinical practice guidelines, based on comprehensive reviews and grading of the existing evidence | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Hornby, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Baker, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Teitelbaum, Jeanne |e verfasserin |4 aut | |
| 700 | 1 | |a Torrance, Sylvia |e verfasserin |4 aut | |
| 700 | 1 | |a Young, Kimberly |e verfasserin |4 aut | |
| 700 | 1 | |a Capron, Alexander M |e verfasserin |4 aut | |
| 700 | 1 | |a Bernat, James L |e verfasserin |4 aut | |
| 700 | 1 | |a Noel, Luc |e verfasserin |4 aut | |
| 700 | 0 | |a The International Guidelines for Determination of Death phase 1 participants, in collaboration with the World Health Organization |e verfasserin |4 aut | |
| 700 | 1 | |a Abdelhak, Tamer |e investigator |4 oth | |
| 700 | 1 | |a Beloucif, Sadek |e investigator |4 oth | |
| 700 | 1 | |a Ammar, Mohammed Salah Ben |e investigator |4 oth | |
| 700 | 1 | |a Baker, Andrew |e investigator |4 oth | |
| 700 | 1 | |a Bernat, James L |e investigator |4 oth | |
| 700 | 1 | |a Black, Peter |e investigator |4 oth | |
| 700 | 1 | |a Bleck, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Bohatyrewicz, Romuald |e investigator |4 oth | |
| 700 | 1 | |a Capron, Alexander M |e investigator |4 oth | |
| 700 | 1 | |a Citerio, Giuseppe |e investigator |4 oth | |
| 700 | 1 | |a Dobb, Geoff |e investigator |4 oth | |
| 700 | 1 | |a Hornby, Laura |e investigator |4 oth | |
| 700 | 1 | |a Jasim, Waleed |e investigator |4 oth | |
| 700 | 1 | |a Jimenez, Edgar |e investigator |4 oth | |
| 700 | 1 | |a Kirste, Günter |e investigator |4 oth | |
| 700 | 1 | |a Kissoon, Niranjan |e investigator |4 oth | |
| 700 | 1 | |a Kwek, Tong Kiat |e investigator |4 oth | |
| 700 | 1 | |a Manara, Alexander |e investigator |4 oth | |
| 700 | 1 | |a Noel, Luck |e investigator |4 oth | |
| 700 | 1 | |a Shemie, Sam D |e investigator |4 oth | |
| 700 | 1 | |a Sinkin, Mikhail |e investigator |4 oth | |
| 700 | 1 | |a Sprung, Charles L |e investigator |4 oth | |
| 700 | 1 | |a Sung, Gene |e investigator |4 oth | |
| 700 | 1 | |a Tallon, John |e investigator |4 oth | |
| 700 | 1 | |a Teitielbaum, Jeanne |e investigator |4 oth | |
| 700 | 1 | |a Torrance, Sylvia |e investigator |4 oth | |
| 700 | 1 | |a Wijdicks, Eelco |e investigator |4 oth | |
| 700 | 1 | |a Young, G Bryan |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Intensive care medicine |d 1993 |g 40(2014), 6 vom: 28. Juni, Seite 788-97 |w (DE-627)NLM000234818 |x 1432-1238 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2014 |g number:6 |g day:28 |g month:06 |g pages:788-97 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00134-014-3242-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2014 |e 6 |b 28 |c 06 |h 788-97 | ||